Used in research settings as a selective inhibitor targeting specific proteasome activities, particularly the immunoproteasome. It is being investigated for its potential in modulating immune responses and treating autoimmune diseases and certain cancers. Its application focuses on preclinical studies to understand disease mechanisms and evaluate therapeutic efficacy in models of inflammation and oncology. Not approved for clinical use; strictly for laboratory research.